These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15094308)

  • 1. Brain inflammation enhances 1-methyl-4-phenylpyridinium-evoked neurotoxicity in rats.
    Goralski KB; Renton KW
    Toxicol Appl Pharmacol; 2004 May; 196(3):381-9. PubMed ID: 15094308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphasic mechanism of the toxicity induced by 1-methyl-4-phenylpyridinium ion (MPP+) as revealed by dynamic changes in glucose metabolism in rat brain slices.
    Maruoka N; Murata T; Omata N; Takashima Y; Fujibayashi Y; Wada Y
    Neurotoxicology; 2007 May; 28(3):672-8. PubMed ID: 17391768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain.
    Renton KW; Nicholson TE
    J Pharmacol Exp Ther; 2000 Aug; 294(2):524-30. PubMed ID: 10900228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
    Staal RG; Sonsalla PK
    J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zocor Forte (simvastatin) has a neuroprotective effect against LPS striatal dopaminergic terminals injury, whereas against MPP+ does not.
    Santiago M; Hernández-Romero MC; Machado A; Cano J
    Eur J Pharmacol; 2009 May; 609(1-3):58-64. PubMed ID: 19292984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo protection of striatal dopaminergic system against 1-methyl-4-phenylpyridinium neurotoxicity by phenobarbital.
    Vizuete ML; Merino M; Cano J; Machado A
    J Neurosci Res; 1997 Aug; 49(3):301-8. PubMed ID: 9260741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of involvement of glutamate-induced excitotoxicity in MPP+ toxicity in striatal dopaminergic terminals: possible involvement of ascorbate.
    Matarredona ER; Santiago M; Machado A; Cano J
    Br J Pharmacol; 1997 Jul; 121(5):1038-44. PubMed ID: 9222565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
    Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
    J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper reduces striatal protein nitration and tyrosine hydroxylase inactivation induced by MPP+ in rats.
    Rubio-Osornio M; Montes S; Pérez-Severiano F; Aguilera P; Floriano-Sánchez E; Monroy-Noyola A; Rubio C; Ríos C
    Neurochem Int; 2009 Jun; 54(7):447-51. PubMed ID: 19428787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of cytochrome P450 2E1 during LPS-induced inflammation in the rat.
    Abdulla D; Goralski KB; Renton KW
    Toxicol Appl Pharmacol; 2006 Oct; 216(1):1-10. PubMed ID: 16712892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of MPP+-treated MN9D cells: a mechanism of toxicity study.
    Wang J; Xu Z; Fang H; Duhart HM; Patterson TA; Ali SF
    Neurotoxicology; 2007 Sep; 28(5):979-87. PubMed ID: 17475336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.
    Wang J; Duhart HM; Xu Z; Patterson TA; Newport GD; Ali SF
    Neurochem Int; 2008 May; 52(6):1037-43. PubMed ID: 18069091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
    Viaggi C; Vaglini F; Pardini C; Caramelli A; Corsini GU
    Neuropharmacology; 2009 Jun; 56(8):1075-81. PubMed ID: 19298832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dioxane on cytochrome P450 enzymes in liver, kidney, lung and nasal mucosa of rat.
    Nannelli A; De Rubertis A; Longo V; Gervasi PG
    Arch Toxicol; 2005 Feb; 79(2):74-82. PubMed ID: 15490126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
    J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of carboxyfullerene on MPP+/MPTP-induced neurotoxicity.
    Lin AM; Yang CH; Ueng YF; Luh TY; Liu TY; Lay YP; Ho LT
    Neurochem Int; 2004 Jan; 44(2):99-105. PubMed ID: 12971912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+).
    Yazdani U; German DC; Liang CL; Manzino L; Sonsalla PK; Zeevalk GD
    Exp Neurol; 2006 Jul; 200(1):172-83. PubMed ID: 16546169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content.
    Dhanasekaran M; Karuppagounder SS; Uthayathas S; Wold LE; Parameshwaran K; Jayachandra Babu R; Suppiramaniam V; Brown-Borg H
    Life Sci; 2008 Jul; 83(3-4):92-5. PubMed ID: 18565546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor-4 regulation of hepatic Cyp3a11 metabolism in a mouse model of LPS-induced CNS inflammation.
    Goralski KB; Abdulla D; Sinal CJ; Arsenault A; Renton KW
    Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G434-43. PubMed ID: 15878984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.